Global Microbiome Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Overview and Scope
Microbiome refers to a group of microbes that live in a certain habitat and include fungi, bacteria, and viruses. It is all of the bacteria, fungi, protozoa, and viruses’ genetic material that dwells on and within the human body. The microbiome’s bacteria also aid in digestion, immune system control, defence against disease-causing bacteria, and the production of vitamins like Vitamin K, which is required for blood clotting, and the B vitamins B12, thiamine, and riboflavin.

Sizing and Forecast
The microbiome market size has grown exponentially in recent years. It will grow from $0.57 billion in 2023 to $0.69 billion in 2024 at a compound annual growth rate (CAGR) of 20.2%.  The  growth in the historic period can be attributed to increased need for immunology, increasing collaborations, government initiatives, increased healthcare expenditure and growth in the number of healthcare facilities.

The microbiome market size is expected to see rapid growth in the next few years. It will grow to $1.24 billion in 2028 at a compound annual growth rate (CAGR) of 16.0%.  The growth in the forecast period can be attributed to rise in healthcare expenditure, rising requirement for customized medicine, increasing funding, technological advances and rising prevalence of chronic diseases. Major trends in the forecast period include use of artificial intelligence for better analysis and to smooth the processes, strategic collaborations and agreements to broaden their product portfolios, boost revenues and establish category leadership, investing in 3d printing technology for more accurate information and increased efficiency, increasing the number of pipeline studies to develop microbiome therapeutics to treat different diseases, consider investing in the development of oncology microbiome therapeutics to maximize revenues, and considering nanotechnology for identifying low-abundant samples and to improve productivity, efficiency and accuracy of the precision technologies being used.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

Segmentation & Regional Insights
The microbiome market covered in this report is segmented –
1) By Type: Bacteria, Archaea, Viruses, Other Microbiomes
2) By Product: Therapeutics, Diagnostics
4) By Technology: Genomics, Proteomics, Metabolomics
3) By End-Use: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases

Sub segments: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Others, Genomics, Proteomics, Metabolomics

North America was the largest region in the microbiome market in 2023. The regions covered in the microbiome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3397&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of inflammatory bowel disease (IBD) is a key factor driving the growth of the microbiome market going forward. Inflammatory bowel disease (IBD) refers to a group of chronic inflammatory disorders that affect the digestive tract, primarily the gastrointestinal (GI) tract the inflammatory bowel disease has placed a spotlight on the gut microbiome’s role in the disease. This has led to a surge in research, diagnostics, and therapies focused on the microbiome, driving the microbiome market’s growth. For instance, in February 2021, according to Temple Health, a US-based non-profit academic healthcare organization, over 1.6 million individuals in the United States are currently living with inflammatory bowel disease (IBD), and its prevalence is expected to increase in the coming years. Therefore, the increasing prevalence of inflammatory bowel disease (IBD) is expected to drive the growth of the microbiome market.

Key Industry Players
Major companies operating in the microbiome market report are Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix, Inc, Locus Biosciences, Osel Inc., Xbiome Co., Ltd, Microba Life Sciences, Biome Australia, Shoreline Biome, Leucine Rich Bio Pvt Ltd, BugSpeaks, KINS Co., Ltd, Yeda Research and Development Co. Ltd, China National Pharmaceutical Group Corporation, Atlas Biomed, BiomX Ltd, ImmuneBiotech Medical Sweden AB, MetaboGen AB, ADM Biopolis, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, Second Genome, OpenBiome, Microbiome Insights Inc., lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome

The microbiome market report table of contents includes:
1. Executive Summary

2. Microbiome Market Characteristics
3. Microbiome Market Trends And Strategies
4. Microbiome Market – Macro Economic Scenario
5. Global Microbiome Market Size and Growth

.

32. Global Microbiome Market Competitive Benchmarking
33. Global Microbiome Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Microbiome Market
35. Microbiome Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model